Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1997 | 12-1996 | 12-1995 | 12-1994 | 12-1993 | |
| Gross Profit | 14,420 | 5,730 | 4,985 | -17,863 | -14,490 |
| Operating Expenses | 25,750 | 20,915 | 22,594 | 0 | 0 |
| Operating Income | -25,750 | -20,915 | -22,594 | N/A | N/A |
| Pre-tax Income | -25,750 | -20,915 | -22,594 | 0 | 0 |
| Net Income Continuous | -25,750 | -20,915 | -22,594 | N/A | N/A |
| Net Income | $-25,750 | $-20,915 | $-22,594 | $N/A | $N/A |
| EBITDA(a) | $-24,240 | $-19,400 | $-21,048 | $1,009 | $1,297 |